Have you ever wondered how medicine grows and evolves? One minute, we’re using a certain procedure or drug to solve a problem in medicine, and the next, things change. That’s how it seems, but actually, the process of introducing new drugs or procedures is incredibly long and complex.
It begins with a hypothesis. A hypothesis is essentially an idea of what might happen or the effect a certain drug or chemical could have on the human body. It’s important to realize that a hypothesis isn’t just a random presumption. It will be based on preexisting evidence or theoretical science that has already been tested. It’s very rare for a study to be approved when the legwork simply isn’t there in the first place.
Once the hypothesis has been put forward, a research study will be suggested. That could be to study everything from the effect of certain enzymes in the liver to a new drug and the impact it has on patients with dementia. The study must be approved by a board of professionals, and it needs to be agreed to be both ethical and valid. Now, you’ve got yourself a ball game.
Forming The Study
Forming the study is all about making sure that you have the right setup in place. For instance, you need the correct number of samples or participants. In the past, boards have been more lenient on how many people need to participate to gain approval for a study. This is why the Wakeman study even reached the press in the first place but these days guidelines are far more strict, and that’s not all. You will also likely need to participate and pair up with another company or organization that can provide you with the tech that you need. Working with preclinical molecular imaging research specialists, doctors are able to use the tech to design and implement a well-grafted study. With the right services like this, they should be able to formulate and discuss results that will be statistically significant.
That’s important because the results must be statistically significant for the paper to be published. And it’s only if the paper is published that the scientific research has any hope of moving to the next stage.
You might think that a drug being successful in one study is when talk begins about it being introduced to the market, but it isn’t. The study needs to be replicated and run again multiple times with the same result, through clinical testing. If it is a drug, it might be tested on animals before human trials begin. As such, after the first study that drug or treatment could still be five or ten years away from entering the market.
So, you might think that medicine moves at a rapid pace, but nothing could be further from the truth. Medicine moves slowly and steadily down the line, only progressing once there is enough evidence to support conclusions and the original results. But there’s a good reason for this. Without it, new medicine and procedures that are not safe could be used in the industry before they have been approved and thoroughly tested.